Delivery Order SPE2DB20D1100-SPE2DB23FC2Y2
Award Date 6/26/23
Potential Completion Date 6/27/23
Potential Value $1.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $386 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 250 milliliters of oxcarbazepine 300 mg/5 ml suspension. The prime contractor will deliver the pharmaceutical product from its Conshohocken, Pennsylvania facility to support Defense Logistics Agency requirements. No major subcontractors or set aside designations were identified. The delivery order was awarded under an existing DLA pharmaceutical supply contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,736.37 to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension in 250 mL quantities. The contract, executed on June 18, 2025, with an ultimate completion date of June 20, 2025, utilizes firm fixed price terms with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under a larger federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,427.33 to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine 300 mg/5 ml suspension in a 250 ml container. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by December 3, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $1,725.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension (250 mL), an anticonvulsant medication used to treat neurological conditions. The delivery order, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $1,155.65 to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension (250 mL), an anticonvulsant medication commonly used in neurological treatment regimens. This firm fixed price delivery order, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, was competitively awarded without set-aside provisions. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,036.14 to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250 ml quantities. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of June 18, 2025, to be performed at the vendor's facility in Conshohocken, Pennsylvania. Oxcarbazepine is a neurological medication commonly used to treat seizure disorders and neuropathic pain conditions,...
- The Defense Logistics Agency awarded a $6,163.17 delivery order to AmerisourceBergen Drug Corp for 250 milliliters of Oxcarbazepine 300 milligrams per 5 milliliters suspension, with a completion date of September 16, 2025. The award was made on a firm fixed price basis with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the awardee for this pharmaceutical supply delivery order. This delivery order is a child...
- The Defense Logistics Agency awarded a $1,088 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension (250 mL), a neurological medication commonly used to treat seizure disorders and neuropathic pain. The contract, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-competitive set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $4,965.13 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Oxcarbazepine 300 mg/5 ml susp 250ml. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical product to a location in Conshohocken, Pennsylvania within a one day period from August 29 to August 30, 2023. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, responsible for worldwide logistics support for all...
- The Defense Logistics Agency awarded a $1,369.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 ml suspension (250 ml) on October 30, 2025, with completion scheduled for October 31, 2025. This award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills the order from its corporate office location at the same address. The...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB23FC2Y2Delivery Order
The Defense Logistics Agency awarded a $1,161 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 250mL of Oxcarbazepine 300mg/5mL suspension. As a prime contractor on an indefinite delivery/indefinite quantity pharmaceuticals contract, Amerisourcebergen will deliver the generic anti-seizure medication to a facility in Conshohocken, Pennsylvania by June 27, 2023 to support the Department of Defense's medical supply needs. No subcontractors or set aside designations were identified. The award draws upon the DLA's portfolio of contracts for pharmaceuticals to stock military treatment facilities and support service members worldwide.
Generated 12/23/23, 3:37 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/26/23 |